Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Adma Biologics (ADMA)

Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,823,944
  • Shares Outstanding, K 237,615
  • Annual Sales, $ 426,450 K
  • Annual Income, $ 197,670 K
  • EBIT $ 139 M
  • EBITDA $ 148 M
  • 60-Month Beta 0.53
  • Price/Sales 12.18
  • Price/Cash Flow 40.39
  • Price/Book 14.82

Options Overview Details

View History
  • Implied Volatility 71.01% ( +1.81%)
  • Historical Volatility 77.79%
  • IV Percentile 69%
  • IV Rank 53.82%
  • IV High 112.27% on 08/06/24
  • IV Low 22.93% on 05/16/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 4,644
  • Volume Avg (30-Day) 4,153
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 61,524
  • Open Int (30-Day) 54,520

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.16
  • Number of Estimates 1
  • High Estimate 0.16
  • Low Estimate 0.16
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.51 +46.03%
on 04/07/25
25.67 -6.08%
on 04/28/25
+3.85 (+19.00%)
since 03/28/25
3-Month
13.50 +78.59%
on 03/04/25
25.67 -6.08%
on 04/28/25
+7.73 (+47.19%)
since 01/29/25
52-Week
6.50 +270.92%
on 04/30/24
25.67 -6.08%
on 04/28/25
+17.53 (+266.41%)
since 04/29/24

Most Recent Stories

More News
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END

POAI : 1.0700 (+0.94%)
AVAI : 0.4700 (+17.50%)
ADMA : 24.11 (-1.63%)
RXRX : 5.72 (-2.05%)
TEM : 54.29 (+0.97%)
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

POAI : 1.0700 (+0.94%)
AVAI : 0.4700 (+17.50%)
ADMA : 24.11 (-1.63%)
RXRX : 5.72 (-2.05%)
TEM : 54.29 (+0.97%)
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

ADMA : 24.11 (-1.63%)
Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag

Fate Therapeutics FATE recently announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational pipeline candidate FT819 for the treatment of active...

KRYS : 170.57 (+0.49%)
JAZZ : 116.41 (+3.12%)
ADMA : 24.11 (-1.63%)
FATE : 1.1700 (-6.40%)
Ironwood Shares Tank on Regulatory Update for Apraglutide

Shares of Ironwood Pharmaceuticals IRWD plunged 31.5% yesterday after it announced regulatory updates on the next-generation GLP-2 analog, apraglutide, which is being developed for treating short bowel...

KRYS : 170.57 (+0.49%)
IRWD : 0.9402 (-3.12%)
JAZZ : 116.41 (+3.12%)
ADMA : 24.11 (-1.63%)
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate

Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying mRNA (sa-mRNA) vaccine candidate, ARCT-2304, for active immunization to protect...

KRYS : 170.57 (+0.49%)
JAZZ : 116.41 (+3.12%)
ADMA : 24.11 (-1.63%)
ARCT : 12.82 (unch)
ADMA Biologics Statement on Tariffs

ADMA : 24.11 (-1.63%)
Ensign Group Invests in Growth With New Facility Acquisitions

The Ensign Group, Inc. ENSG recently announced a series of strategic acquisitions across Washington and California. These acquisitions, effective April 1, 2025, underscore the company’s commitment to...

OPCH : 30.69 (-6.92%)
ADMA : 24.11 (-1.63%)
ENSG : 128.12 (+0.83%)
BVS : 7.56 (+1.75%)
Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook

CEO Adam Grossman highlighted a 65% year-over-year jump in total revenue and a staggering 309% increase in adjusted EBITDA for 2024.

IJR : 100.84 (+0.65%)
ADMA : 24.11 (-1.63%)
VTI : 272.66 (+0.60%)
XBI : 81.88 (+0.63%)
Adma Biologics: Q4 Earnings Snapshot

Adma Biologics: Q4 Earnings Snapshot

ADMA : 24.11 (-1.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying...

See More

Key Turning Points

3rd Resistance Point 26.97
2nd Resistance Point 25.72
1st Resistance Point 24.92
Last Price 24.11
1st Support Level 22.87
2nd Support Level 21.62
3rd Support Level 20.82

See More

52-Week High 25.67
Last Price 24.11
Fibonacci 61.8% 18.35
Fibonacci 50% 16.08
Fibonacci 38.2% 13.82
52-Week Low 6.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar